Logo
Menu
Overview

Summary

Affiliates

Contact details3

Officers1

Tax information

Links between entities4

Finance10

Identification numbers1

Related companies1

FAQ

Find out more about how much GSK Biologicals - SmithKline Beecham Biologicals
earned last year and more by getting full access

Last updated: Jun 07, 2024

GLAXOSMITHKLINE BIOLOGICALS

Active

is not in process of liquidation on Jun 7, 2024

Public limited company

Belgium 01 Jul 1990 (34 years ago)

Share viaTwitterFacebookLinkedin

Summary

NameGlaxoSmithKline Biologicals
Short NameGSK Biologicals - SmithKline Beecham Biologicals
Brand NameGLAXOSMITHKLINE BIOLOGICALS
Status
  • ActiveNormal condition from 01 Jul 1990
JurisdictionActiveBelgium
Enterprise numberCode0440.872.918
Establishment number2.263.209.740
LEI Code
  • 5493004ZNHN6CAC59L18
CAGE Code
  • B4900
Incorporation Date01 Jul 1990 (34 years ago) / 446 companies with the same date
Paid share capital8.379.632.620,82 EUR
Legal formPublic limited company
Type of activity

Affiliates

Local connections
Biowi*******

ActiveBelgium

Biowi*******

ActiveBelgium

CanCh********

ActiveBelgium

Contact details

Legal addressRue de l'Institut 89, 1330 Rixensart
Phone
  • +32************
  • 02/*******
Fax
  • +32************

Officers

individual

IndividualBelgium

Niti Gautam

POC

Get ahead with complete company information - register now.

Join the 50,000+ businesses already using B2BHint.

Sign up

Tax information

Annual assemblyjuni
End date financial year31 december
Employees no.1000 werknemers of meer
VAT
  • Pays VATYes
  • Registration date01 Jan 2008

Links between entities

TypeDateName
Related01 Oct 1990SMITH KLINE - RIT
Related01 Oct 1990Smithkline Biologicals

Find out all the information about the company

Get full access to the data

Financial reports

YearTurnoverNet profitTotal assetsOther
20206,474,854,776.6 EUR
(~$7,383,488,520)
1,779,646,779.04 EUR
(~$2,029,389,387)
20,382,686,917.01 EUR
(~$23,243,044,061)
View full report
20196,786,443,995.68 EUR
(~$7,599,661,097)
1,991,251,239.91 EUR
(~$2,229,862,148)
19,733,927,997.8 EUR
(~$22,098,637,371)
View full report
20184,691,878,572.38 EUR
(~$5,537,081,904)
515,217,822.22 EUR
(~$608,030,075)
17,645,925,844.83 EUR
(~$20,824,694,237)
View full report

Find out all the information about the company

Get full access to the data

View more data

Identification numbers

Data from the LEI register
  • 5493004ZNHN6CAC59L18
  • Legal nameGLAXOSMITHKLINE BIOLOGICALS
  • Registration date07 Feb 2014
  • StatusActiveA transfer to another issuing agency (LOU) was requested for this LEI.
  • IssuerActiveLONDON STOCK EXCHANGE LEI LIMITED
  • Last updated24 Oct 2023
  • Next renewal08 Jun 2023

Related companies by address

Frequently asked questions

Where is GSK Biologicals - SmithKline Beecham Biologicals's headquarters?

GSK Biologicals - SmithKline Beecham Biologicals's headquarters is located at Rue de l'Institut 89, 1330 Rixensart

What is GSK Biologicals - SmithKline Beecham Biologicals's industry?

GSK Biologicals - SmithKline Beecham Biologicals is in the industry of Manufacture of pharmaceutical preparations

How many employees does GSK Biologicals - SmithKline Beecham Biologicals have?

GSK Biologicals - SmithKline Beecham Biologicals has 1000 werknemers of meer employees

What year was GSK Biologicals - SmithKline Beecham Biologicals started?

GSK Biologicals - SmithKline Beecham Biologicals was started in 1990

What is the LEI number of GSK Biologicals - SmithKline Beecham Biologicals?

GSK Biologicals - SmithKline Beecham Biologicals LEI number is 5493004ZNHN6CAC59L18

What is the CAGE number of GSK Biologicals - SmithKline Beecham Biologicals?

GSK Biologicals - SmithKline Beecham Biologicals CAGE number is B4900

How much does GSK Biologicals - SmithKline Beecham Biologicals generate in sales?

GSK Biologicals - SmithKline Beecham Biologicals's sales is $7,383,488,520

How much profit does GSK Biologicals - SmithKline Beecham Biologicals make?

GSK Biologicals - SmithKline Beecham Biologicals's profit is $2,029,389,387

Sources: FOD Economie, KMO, Middenstand en Energie